Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 10, 2011, Pages 1681-1690

  Akanji, Abayomi O ^a   Al Isa, Abdulwahab N ^a   Thalib, Lukman ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

adolescents; Arabs; coronary artery disease; dyslipidemia; fibrinogen; lipoprotein(a); obesity; PAI 1

Indexed keywords

APOLIPOPROTEIN B; BIOLOGICAL MARKER; FIBRINOGEN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADOLESCENCE; ADOLESCENT; ADULT; AGE; ARAB; ARTICLE; BODY MASS; CHILD; DIET; EXERCISE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INCOME; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; THROMBOGENICITY;

ADOLESCENT; ARABS; BIOLOGICAL MARKERS; CHILD; CORONARY ARTERY DISEASE; FEMALE; FIBRINOGEN; HUMANS; LIPOPROTEIN(A); MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; YOUNG ADULT;

EID: 80054921129     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.645     Document Type: Article

References (50)

1. National Cholesterol Education Program (NCEP) Expert Panel. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002;106;3143-421.
2. Dimitrijevic-Sreckovic V, Colak E, Djordjevic P, Gostiljac D, Sreckovic B, Popovic S, et al. Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome. Clin Chem Lab Med 2007;45:1140-4. (Pubitemid 47396271)
3. Glowinska B, Urban M, Koput A, Galar M. New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents. Atherosclerosis 2003;167:275-86. (Pubitemid 36773527)
4. Glowinska B, Urban M, Koput A. Cardiovascular risk factors in children with obesity, hypertension and diabetes: Lipoprotein( a) levels and body mass index correlate with family history of cardiovascular disease. Eur J Pediatr 2002;161:511-8.
5. Mauras N, Delgiorno C, Kollman C, Bird K, Morgan M, Sweeten S, et al. Obesity without established comorbidities of the metabolic syndrome is associated with a proinflammatory and prothrombotic state, even before the onset of puberty in children. J Clin Endocrinol Metab 2010;95:1060-8.
6. Hamstein A, Eriksson P. Fibrinolysis and atherosclerosis. Bailliere's Clin Haem 1995;8:345-63.
7. Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease, a review. Atherosclerosis 1992;95:105-17.
8. Thomson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC (for the ECAT Angina Pectoris Study Group). Hemostatic factors and the risk of mycocardial infarction or sudden death in patients with angina. N Engl J Med 1995;332:635-41.
9. Hamstein A, Wiman B, DeFaire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985;313:1557-63. (Pubitemid 16177394)
10. Ernst E. Fibrinogen: Its emerging role as a cardiovascular risk factor. Angiology 1994;45:87-93. (Pubitemid 24058334)
11. Meade TW. Fibrinogen in ischaemic heart disease. Eur Heart J 1995;16(Suppl A):31-5.
12. Kannel WB. Influence of fibrinogen on cardiovascular disease. Drugs 1997;54(Suppl 3):32-40. (Pubitemid 27488853)
13. Montalescot G, Collet JP, Choussat R, Thomas D. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J 1998; 19(Suppl H):H11-7. (Pubitemid 28321418)
14. Frank S, Durovic S, Kostner GM. The assembly of lipoprotein Lp(a). Eur J Clin Invest 1996;26:109-14. (Pubitemid 26063434)
15. Scanu AM. Structural and functional polymorphism of lipoprotein (a): Biological and clinical implications. Clin Chem 1995; 41:170-2.
16. Lip GY, Jones AF. Lipoprotein(a) and vascular disease: Thrombogenesis and atherogenesis. Q J Med 1995;88:529-39.
17. Sandkamp M, Funke H, Schulte H, Kohler E, Assman G. Lipoprotein (a) is an independent risk factor for myocardial infarction at a young age. Clin Chem 1990;36:20-3.
18. Stubbs P, Seed M, Lane D, Collinson P, Kendall F, Noble M. Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes. Eur Heart J 1998; 19:1355-64. (Pubitemid 28427137)
19. Budde T, Fechtrup C, Bosenberg E, Vielhauer C, Enbergs A, Schulte H, et al. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis. Arterioscler Thromb 1994;14: 1730-6.
20. Seman LJ, DeLuca C, Jenner JL, Cupples LA, McNamara JR, Wilson PW, et al. Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem 1999;45: 1039-46. (Pubitemid 29340541)
21. Marcovina SM, Koschinsky ML. Lipoprotein(a) as a risk factor for coronary artery disease. Am J Cardiol 1998;82:57U-66U. (Pubitemid 29047617)
22. Akanji AO. Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population. Ann Clin Biochem 2000;37:360-6.
23. Akanji AO, Abdullah A, Tahzeeb S. Lipoprotein (a), tissue plasminogen activator and plasminogen activator inhibitor-1 levels in hyperlipidemic patients in Kuwait. Eur J Clin Invest 1997;27:380-6. (Pubitemid 27242508)
24. Akanji AO, Al-Shayji IA, Kumar P. Metabolic and anthropometric determinants of serum Lp(a) concentrations and apo(a) polymorphism in a healthy Arab population. Int J Obes Relat Metab Disord 1999;23:855-62. (Pubitemid 29378261)
25. Akanji AO, Al-Shayji I. The relationships between insulin and plasminogen activator inhibitor-1 levels: Assessment in groups of subjects with dyslipidemia and hypertension. Clin Chim Acta 1998;274:41-52. (Pubitemid 28243262)
26. Abdella N, Mojiminiyi OA, Akanji AO, Al-Mohammadi H, Moussa MA. Serum lipoprotein(a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients. J Diabetes Complications 2001;15:270-6. (Pubitemid 32754818)
27. Al-Isa AN, Thalib L, Akanji AO. Circulating markers of inflammation and endothelial dysfunction in Arab adolescent subjects: Reference ranges and associations with age, gender, body mass and insulin sensitivity. Atherosclerosis 2010;208: 543-9.
28. Akanji AO, Thalib L, Al-Isa AN. Folate, vitamin B12 and total homocysteine concentrations in Arab adolescent subjects: Reference ranges and potential determinants. Nutrition, Metabolism & Cardiovascular Diseases 2010, in press (doi:10.1016/j.numecd.2010.10.020).
29. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: International survey. Br Med J 2000;320:1240-3. (Pubitemid 30240471)
30. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol without use of the preparative centrifuge. Clin Chem 1972;18:499-502.
31. Al-Owaish RA. Descriptive epidemiology of acute myocardial infarction in Kuwait. Bull WHO 1990;61:509-16.
32. Ahmed AF, Abdelsalam SA, Mahmoud ME, Gadri MA. A case control study of the incidence of coronary heart disease risk factors in Saudis at Almadina Almounawarah. Saudi Med J 1993;14:146-51.
33. Radovanovic Z. Mortality patterns in Kuwait: Inferences from death certificate data. Eur J Epidemiol 1994;10:733-6.
34. El-Mugamer IT, Ali Zayat AS, Hossain MM, Pugh RN. Diabetes, obesity and hypertension in urban and rural people of Bedouin origin in the United Arab Emirates. J Trop Med Hyg 1995;98:407-15. (Pubitemid 26023658)
35. Akanji AO, Al-Suleiman AS, Tahzeeb S, Prabha K. A lipid clinic service in Kuwait: Preliminary observations. Med Princ Pract 1996;5:151-9. (Pubitemid 126509678)
36. Alsaeid M, Alsaeid K, Fatania HR, Sharma PN, Abd-Elsalam R. Serum lipoprotein(a) concentrations among Arab children: A hospital-based study in Kuwait. Ann Trop Paediatr 1998;18: 243-8. (Pubitemid 28438355)
37. Alsaeid M, Al-Essa M, Alsaeid K, Sharma PN. Lipoprotein A profiles in Arab newborns. Pediatr Int 1999;41:65-9. (Pubitemid 29268636)
38. Akanji AO. The relationships between plasma lipoproteins and apolipoprotein A-1 and B levels in hyperlipidaemic patients in Kuwait. J Kuwait Med Assoc 1997;29:418-22.
39. Akanji AO. Comparative assessment of three commercially available methods for measurement of plasma apolipoprotein A-1 and B levels. Kuwait Med J 1999;31:148-51.
40. Fujii C, Sakakibara H, Kondo T, Yatsuya H, Tamakoshi K, Toyoshima H. Plasma fibrinogen levels and cardiovascular risk factors in Japanese schoolchildren. J Epidemiol 2006;16:64-70. (Pubitemid 43414598)
41. Steene-Johannessen J, Kolle E, Reseland JE, Anderssen SA, Andersen LB. Waist circumference is related to low-grade inflammation in youth. Int J Pediatr Obes 2010;5:313-9.
42. Amemiya S, Dobashi K, Urakami T, Sugihara S, Ohzeki T, Tajima N. Metabolic syndrome in youths. Pediatr Diabetes 2007;8(Suppl 9):48-54. (Pubitemid 350066648)
43. Galli-Tsinopoulou A, Grammatikopoulou M, Stylianou C, Emmanouilidou E, Kokka P, Varlamis G. Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese. J Endocrinol Invest 2010;33:549-53.
44. Velásquez-Mieyer PA, Cowan PA, Pérez-Faustinelli S, Nieto-Martínez R, Villegas-Barreto C, Tolley EA, et al. Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents. Diabetes Care 2008;31:770-5.
45. Halle M, Korsten-Reck U, Wolfarth B, Berg A. Low-grade systemic inflammation in overweight children: Impact of physical fitness. Exerc Immunol Rev 2004;10:66-74.
46. Labayen I, Ruiz JR, Ortega FB, Loit HM, Harro J, Veidebaum T, et al. Intergenerational cardiovascular disease risk factors involve both maternal and paternal BMI. Diabetes Care 2010;33:894-900.
47. Sosothikul D, Seksarn P, Lusher JM. Pediatric reference values for molecular markers in hemostasis. J Pediatr Hematol Oncol 2007;29:19-22. (Pubitemid 46143021)
48. Aasvee K, Kurvinen E, Sundvall J, Jauhiainen M, Tur I. Aggregation of lipoprotein and inflammatory parameters in families with a history of premature myocardial infarction: The Tallinn myocardial infarction study. Clin Chem Lab Med 2008;46: 1602-8.
49. Nienaber C, Pieters M, Kruger SH, Stonehouse W, Vorster HH. Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1 activity, fibrinogen and thrombin-antithrombin complex in African adolescents. Blood Coagul Fibrinolysis 2008;19:361-8.
50. Akinci G, Akinci B, Coskun S, Bayindir P, Hekimsoy Z, Ozmen B. Evaluation of markers of inflammation, insulin resistance and endothelial dysfunction in children at risk for overweight. Hormones (Athens) 2008;7:156-62.